Articles

Editor’s note: Jerome Granato, M.D., is the medical director of the coronary care unit at Allegheny General Hospital in Pittsburgh, Pa. His facility started looking at ways to cut its...

The FDA’s approval of the Melody valve is widely viewed as a positive sign that may help other transcatheter valves to follow.

The FDA recently gave market clearance for Medtronic’s Melody Transcatheter Pulmonary Valve, the first transcatheter valve approved in the United States. The cardiology community expects this to...

As cutting-edge technologies collide with innovative surgical and interventional treatments for multiple coronary or vascular issues, a hybrid approach is emerging as the best path of action.

The general public usually does not take a big interest in cardiology or the interventional devices used to treat cardiac conditions until a family member or someone famous makes headlines due to...

March 9, 2010 – The most recent data from 30 late-breaking clinical trials is being highlighted during the American College of Cardiology (ACC) 2010 scientific sessions, March 14-16 in Atlanta.

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from...

The Washington Hospital (TWH), a 239-bed not-for-profit community hospital in the highly competitive cardiac market of western Pennsylvania, gained an edge against the competition by automating...

Atherosclerosis is the leading cause of cardiovascular disease (CAD), heart attacks and death in both men and women in the United States. However, advances in diagnosing and treating coronary...

The intra-aortic balloon pumps (IABPs) have been the gold standard for minimally invasive circulatory support for 40 years, but they were joined in recent years by percutaneously deployed...